Flores Saul, Iliopoulos Ilias, Loomba Rohit S, Opoka Amy M, Sahay Rashmi D, Fei Lin, Cooper David S
Section of Critical Care Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, United States.
Division of Critical Care, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States.
J Pediatr Intensive Care. 2020 Dec;9(4):241-247. doi: 10.1055/s-0040-1709658. Epub 2020 Apr 29.
We conducted a candidate gene association study to test the hypothesis that different gene polymorphisms will be associated with corticosteroid responsiveness and study outcomes among children undergoing congenital heart surgery. This is a prospective observational cohort study at a large, tertiary pediatric cardiac center on children undergoing corrective or palliative congenital heart surgery. A total of 83 children were enrolled. DNA was isolated for three polymorphisms of interest namely N363 (rs56149945) and 9β (rs6198) associated with increased sensitivity to corticosteroids and I (rs41423247) associated with decreased sensitivity to corticosteroids. Duration of inotropic use, low cardiac output scores (LCOS), and vasoactive inotrope scores were examined in relation to these three polymorphisms. Using Kaplan-Meier analysis, heterozygous individuals showed longer transcriptional intermediary factor (TIF) compared with wild type for N363 polymorphism ( = 0.05). In multivariable Cox regression, heterozygous alleles for 9β polymorphism showed significantly shorter TIF compared with wild type (hazard ratio = 2.04 [1.08-3.87], = 0.03). The relationship between lower LCOS scores and alleles groups was significant for 9β heterozygous polymorphism only (1.5 [1-2.2], = 0.01) in comparison to wild type and homozygous. The presence of heterozygote alleles for the increased corticosteroid sensitivity is associated with longer TIF compared with wild type. Conversely, the presence of heterozygous alleles for the decreased sensitivity to corticosteroids is associated with shorter TIF compared with wild type.
我们进行了一项候选基因关联研究,以检验不同基因多态性与先天性心脏病手术患儿的皮质类固醇反应性及研究结果相关的假设。这是一项在一家大型三级儿科心脏中心对接受先天性心脏病矫正或姑息手术的儿童进行的前瞻性观察队列研究。共纳入83名儿童。提取了DNA,检测了三个感兴趣的多态性位点,即与皮质类固醇敏感性增加相关的N363(rs56149945)和9β(rs6198),以及与皮质类固醇敏感性降低相关的I(rs41423247)。研究了这三个多态性位点与血管活性药物使用时间、低心排血量评分(LCOS)和血管活性正性肌力药物评分之间的关系。使用Kaplan-Meier分析,对于N363多态性,杂合子个体的转录中间因子(TIF)时间比野生型更长(P = 0.05)。在多变量Cox回归分析中,9β多态性的杂合子等位基因与野生型相比,TIF时间显著缩短(风险比 = 2.04 [1.08 - 3.87],P = 0.03)。仅9β杂合多态性与野生型和纯合子相比,较低的LCOS评分与等位基因组之间的关系具有显著性(1.5 [1 - 2.2],P = 0.01)。与野生型相比,皮质类固醇敏感性增加的杂合子等位基因的存在与更长的TIF时间相关。相反,与野生型相比,皮质类固醇敏感性降低的杂合子等位基因的存在与更短的TIF时间相关。